scholarly journals Pharmacological Investigation of Genus Pistacia

2021 ◽  
Author(s):  
Abdur Rauf ◽  
Yahya S. Al-Awthan ◽  
Naveed Muhammad ◽  
Muhammad Mukarram Shah ◽  
Saikat Mitra ◽  
...  

Several plants in the genus Pistacia are used in the treatment of various pathogenic and non-pathogenic disorders. Especially important are the major species belonging to this genus such as Pistacia lentiscus, Pistacia atlantica, Pistacia vera, Pistacia terebinthus, and Pistacia khinjuk, among others; these have been reported for their potential benefits both in medical and commercial purposes. In addition, members of this genus exhibit numerous ethnomedicinal uses, such as analgesic, anti-inflammatory, anticancer, antimicrobial, antihypertension, antihyperlipidemic, antiviral, and antiasthma. In light of these potential uses, the present chapter aimed to collect and summarize the literature about all of this medicinal information. Accordingly, this chapter focuses on the pharmacological uses and benefits of the genus Pistacia, especially those related to health issues.

Biomolecules ◽  
2020 ◽  
Vol 10 (12) ◽  
pp. 1619
Author(s):  
Cornelia Fursenco ◽  
Tatiana Calalb ◽  
Livia Uncu ◽  
Mihaela Dinu ◽  
Robert Ancuceanu

Solidago virgaurea L. (European goldenrod, Woundwort), Asteraceae, is a familiar medicinal plant in Europe and other parts of the world, widely used and among the most researched species from its genus. The aerial parts of European goldenrod have long been used for urinary tract conditions and as an anti-inflammatory agent in the traditional medicine of different peoples. Its main chemical constituents are flavonoids (mainly derived from quercetin and kaempferol), C6-C1 and C6-C3 compounds, terpenes (mostly from the essential oil), and a large number of saponin molecules (mainly virgaureasaponins and solidagosaponins). Published research on its potential activities is critically reviewed here: antioxidant, anti-inflammatory, analgesic, spasmolitic, antihypertensive, diuretic, antibacterial, antifungal, antiparasite, cytotoxic and antitumor, antimutagenic, antiadipogenic, antidiabetic, cardioprotective, and antisenescence. The evidence concerning its potential benefits is mainly derived from non-clinical studies, some effects are rather modest, whereas others are more promising, but need more confirmation in both non-clinical models and clinical trials.


2019 ◽  
Vol 322 (2) ◽  
pp. 1127-1131 ◽  
Author(s):  
Nadjia Hamlat ◽  
Adel Benarfa ◽  
Brahim Beladel ◽  
Samir Begaa ◽  
Mohammed Messaoudi ◽  
...  

2021 ◽  
pp. 1531-1538
Author(s):  
Hassan Sher ◽  
Hammad Ahmad Jan ◽  
Arshad Mehmood Abbasi ◽  
Ikram Ur Rahman ◽  
Rainer W. Bussmann ◽  
...  

Urban Health ◽  
2019 ◽  
pp. 217-229
Author(s):  
Carlos Dora

Urban development interventions in a variety of sectors, including in transport, housing, land-use planning, waste management, and energy can generate substantial health benefits to affected communities. These opportunities for health can be overlooked and unnecessary health risks and costs caused and potential benefits foregone if health issues are not explicitly considered as part of urban projects, plans, and strategies. Environmental health assessments bring together inputs from science and experience using a range of approaches, including community consultations and assessment of local environmental conditions to determine how local projects, plans and policies can improve population health. Formal environmental health assessments then stand to help guide thinking about how environmental factors can create health in cities, and provide a voice for children and other groups whose perspective is often not included in decision making. This chapter provides an introduction to environmental health assessments with an eye to equipping local actors to proactively contribute to creating health and health equity among urban populations, as a key tool for including Health in All Policies.


Sign in / Sign up

Export Citation Format

Share Document